Chemoradiation for advanced primary vulval cancer

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2011, Pages

  Shylasree, T S ^a   Bryant, Andrew ^b   Howells, Robert E J ^c  

^a TATA MEMORIAL HOSPITAL   (India)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RECURRENCE FREE SURVIVAL; REVIEW; SKIN TOXICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; UROGENITAL TRACT DISEASE; VULVA CANCER; ADJUVANT THERAPY; FEMALE; MORTALITY; SQUAMOUS CELL CARCINOMA; VULVA TUMOR;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; NEOADJUVANT THERAPY; VULVAR NEOPLASMS;

EID: 79955646084     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003752.pub3     Document Type: Review

References (62)

1. Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecologic Oncology 2008;108(3):584-90.
2. Maneo A, Landoni F, Colombo A, Colombo A, Villa A, Caspani G. Randomised study between neoadjuvant chemoradiotherapy and primary surgery for the treatment of advanced vulval cancer. International Journal of Gynecological Cancer. 2003; Vol. 13 Suppl 1:6, Abstract PL 19.
3. Mulayim N, Silver DF, Schwartz PE, Higgins S. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecologic Oncology 2004;93:659-66.
4. Aki A, Aki M, Russell AH, Kinney WK. Prophylactic chemoradiation of inguinofemoral lymphnodes in patients with locally extensive vulvar cancer. International Journal of Radiation Oncology, Biology, Physics 2000;48:415-20.
5. Beller U, Quinn M, Benedet J, Creasman W, Ngan H, Maisonneuve P, et al.Carcinoma of the vulva. International Journal of Gynecology and Obstetrics 2006;95 Suppl 1:7-27.
6. Benedetti-Panici P, Greggi S, Scambia G, Salerno G, Mancuso S, et al.Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecologic Oncology 1993;50:49-53.
7. Berek JS, Heaps JM, Fu YS, Juillard GJ, Hacker NF. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecologic Oncology 1991;42(3):197-201. [MEDLINE: 35].
8. Beriwal S, Heron DE, Kim H, King G, Shogan J, Bahri S, et al.Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. International Journal of Radiation Oncology, Biology, Physics 2006;64(5):1395-400.
9. Beriwal S, Coon D, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, et al.Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecologic Oncology 2008;109(2):291-5.
10. Carson LF, Twiggs LB, Adcock LL, Prem KA, Potish RA. Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project. Journal of Reproductive Medicine 1990;35(11):1029-32. [MEDLINE: 18].
11. Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecologic Oncology 1997;66(2):258-61. [MEDLINE: 1].
12. de Hullu JA, van der Zee AGJ. Surgery and radiotherapy in vulvar cancer. Critical Reviews in Oncology/Hematology 2006;60(1):38-58.
13. Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecologic Oncology 1995;59(1):51-6. [MEDLINE: 32].
14. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. [Review] [167 refs]. Critical Reviews in Oncology/Hematology 2006;60(3):227-41.
15. Geisler JP, Manahan KJ, Buller ER. Neoadjuvant chemotherapy in vulvar cancer:Avoiding primary exenteration. Gynecologic Oncology 2006;100:53-7.
16. Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecologic Oncology 2005;99(3):640-4.
17. Han SC, Kim DH, Higgins SA, Carcangiu M-L, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. International Journal of Radiation Oncology, Biology, Physics 2000;47(5):1235-44.
18. Han SC, Rutherford TJ, Higgins SA, Kim DH, Kacinski BM. Concurrent chemotherapy and radiation therapy as primary treatment for locally advanced vulvar carcinoma. Gynecologic Oncology: Society of Gynecologic Oncologists - Abstracts 2000;76:230-84.
19. Iversen T. Irradiation and bleomycin in the treatment of inoperable vulvar carcinoma. Acta Obstetricia Gynecologica Scandinavica 1982;61:195-7.
20. Jolicoeur M, Nguyen T-V, Goffin F, David S, Devieux A, Provencher D, et al.Conservative management of advanced or recurrent vulvar carcinoma. International Journal Gynecological Cancer. 2004; Vol. 14, issue suppl 1:52, abstract 177.
21. Koh WJ, Wallace III HJ, Greer BE. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. International Journal of Radiation Oncology, Biology, Physics 1993;26:809-16.
22. Landoni F, Maneo A, Zanetta G, Colombo A, Nava S, Placa F, et al.Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecologic Oncology 1996;61(3):321-7. [MEDLINE: 14].
23. Landrum LM, Lanneau GS, Skaggs VJ, Gould N, Walker JL, McMeekin DS, et al.Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecologic Oncology 2007;106(3):521-5.
24. Levin W, Goldberg G, Altaras M, Bloch B, Shelton MG. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecologic Oncology 1986;25:20-5.
25. Lupi G, Raspagliesi F, Zucali R, et al.Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996;77:1472-8.
26. Makinen J, Salmi T, Gronroos M. Individually modified treatment of invasive squamous cell vulvar cancer: a 10 year experience. Annales Chirurgiae et Gynaecologiae 1987;76 Suppl 202:68-71.
27. Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, et al.Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. International Journal of Radiation Oncology, Biology, Physics 2000;48(4):1007-13. [MEDLINE: 31].
28. Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. International Journal of Radiation Oncology, Biology, Physics 1998;42(1):79-85. [MEDLINE: 6].
29. Moore DH. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?. [Review] [77 refs]. Gynecologic Oncology 2009;113(3):379-83.
30. Roberts WS, Kavanagh JJ, Greenberg H, Bryson SC, LaPolla JP, Townsend PA, et al.Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecologic Oncology 1989;34(2):183-6. [MEDLINE: 23].
31. Roberts WS, Hoffman MS, Kavanagh JJ, Fiorica JV, Greenberg H, Finan MA, et al.Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecologic Oncology 1991;43(3):233-6. [MEDLINE: 13].
32. Russell AH, Mesic JB, Scudder SA, et al.Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecologic Oncology 1992;47:14-20.
33. Scheistroen M, Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncologica 1993;32(6):657-61.
34. Sebag-Montefiore DJ, Mclean C, Arnott SJ, et al.Treatment of advanced carcinoma of the vulva with chemoradiotherapy - can exenterative surgery be avoided. International Journal of Gynecological Cancer 1994;4:150-5.
35. Stehman FB, Look KY. Carcinoma of the vulva. [Review] [168 refs]. Obstetrics and Gynecology 2006;107(3):719-33.
36. Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecologic Oncology 2008;108(3):577-83.
37. Thomas G, Dembo A, DePetrillo A, Pringle J, Ackerman I, Bryson P, et al.Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecologic Oncology 1989;34(3):263-7. [MEDLINE: 28].
38. Wagenaar HC, Colombo N, Vergote I, et al.Blemomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative group study. European Organization for Research and Treatment of Cancer. Gynecologic Oncology 2001;81:348-54.
39. Wahlen SA, Slater JD, Wagner RJ, Wang WA, Keeney ED, Hocko JM, et al.Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995;75(9):2289-94. [MEDLINE: 33].
40. Paclitaxel in Treating patients with Locally Advanced, Metastatic, or Recurrent Cancer of the vulva. Ongoing study February 2001.
41. NCT 00068406. Phase II study of radiotherapy and cisplatin followed by resection of residual disease in patients with locally advanced squamous cell carcinoma of the vulva that is not amendable to standard radical vulvectomy.. http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=322259&version=patient&protocolsearchid=2094462.
42. Andersen BL, Hacker NF. Psychosexual adjustment following vulvar surgery. Obstetrics and Gynecology 1983;62:457-62.
43. Ansink A, Velden van der J, Collingwood M. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD002036].
44. Benedet JL, Bender H, Jones H 3rd, Nguan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines of gynaecological cancers. International Journal of Gynaecolgical Obstetrics 2000;70(2):209-62.
45. Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer; rationale and results. Cancer 1982;49:1085-91.
46. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
47. Higgins JPT, Green S, editors. Cochrane Handbook for systematic Reviews of Interventions Version 5.0.0 [updated February] 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
48. CTCAE. Common Terminology Criteria for Adverse Events. (http://ctep.cancer.gov/forms/CTCAEv3.pdf) 9th August 2006; Vol. v3.0 (CTCAE).
49. Cummings B, Keane T, Thomas G, Harwoord A, Rider W. Results and toxicity of the treatment of anal carcinoma by radiation therapy and chemotherapy. Cancer 1984;54:2062-8.
50. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (editors). Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edition). London: BMJ Publication Group, 2001.
51. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
52. FIGO Committee. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. International Journal of Gynecology and Obstetrics 2009;105:103-4.
53. Gaffney DK, Du Bois A, Narayan A, et al.Patterns of care for radiotherapy in vulvar cancer: A Gynecologic Cancer Intergroup study. International Journal of Gynecological Cancer 2009;19(1):163-7.
54. Hacker NF, Berek JS, Juillard JF, Lagasse LD. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer 1984;54:2056-61.
55. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
56. Jemal A, Siegel R, Ward E, et al.Cancer statistics. CA: A Cancer Journal for Clinicians 2006;56:106-30.
57. Maggioni A, et al.Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan. Gynecologic Oncology 2009;114(1):64-8.
58. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
59. Platz CE, Benda JA. Female genital tract cancer. Cancer 1995;75 Suppl(1):270-94.
60. Shepherd JH. Revised FIGO staging for gynaecological cancer. British Journal of Obstetrics and Gynaecology 1989;96(8):889-92.
61. Stroup AM, Harlan LC, Trimble EL. Demographic, clinical and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecologic Oncology 2008;108:577-83.
62. Velden J van der, Lindert AC van, Gimbrere CH, Oosting H, Heintz AP. Epidemiologic data on vulvar cancer: comparison of hospital with population-based data. Gynecologic Oncology 1996;62:379-83.